EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Does Genetic Variation in PNPLA3, TM6SF2 and HSD17B13 have a Role in the Development or Prognosis of Hepatocellular Carcinoma in Turkish Patients with Hepatitis B?

Coskun Ozer Demirtas, Fatih Eren, Demet Yilmaz, Osman Cavit Ozdogan, Feyza Gunduz

Journal of Gastrointestinal and Liver Diseases · 2024

DOI: 10.15403/jgld-5474 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, 2024. Verfasst von Coskun Ozer Demirtas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Marmara University School of Medicine, Division of Gastroenterology and Hepatology, Istanbul; Marmara University, Institute of Gastroenterology, Ista…. Hauptthemen laut MEDLINE: Membrane Proteins, Polymorphism, Single Nucleotide, Lipase, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: Progression to hepatocellular carcinoma (HCC) is restricted by viral suppression in chronic hepatitis B (CHB); however, some patients still progress despite antiviral therapy. Presence of single nucleotide polymorphisms (SNPs) such as PNPLA3 rs738409 and TM6SF2 rs58542926 are associated with the development and progression of steatotic liver disease to HCC, whereas a splice variant in HSD17B13 rs72613567:TA has been shown to be protective. We investigated the role of these SNPs in the development or prognosis of HCC in pure CHB etiology, in the absence of hepatic steatosis, remains unknown. Materials: We analysed PNPLA3 rs738409, TM6SF2 rs58542926, and HSD17B13 rs72613567 SNPs in a prospectively recruited cohort (n=323) consisting of healthy controls, CHB and CHB-HCC patients without hepatic steatosis. SNPs were determined by PCR analysis and associations for the alleles and genotypes were investigated using adjusted-logistic regression analyses. The overall survival (OS) data were collected from CHB-HCC patients for survival analysis.

Results

The genotype and allelic distribution of PNPLA3 rs738409, TM6SF2 rs58542926, and HSD17B13 rs72613567 were similar between healthy controls, CHB, and CHB-HCC groups. No genotype, allele or haplotype analysis was found to be associated with increased risk for CHB-HCC. Survival analysis revealed no genotype or allele to be associated with OS in patients with CHB-HCC.

Conclusions

We could not demonstrate any association of PNPLA3 rs738409, TM6SF2 rs58542926, and HSD17B13 rs72613567 with the development or prognosis of CHB-HCC, supporting the initial hypothesis that they should be considered specific hotspots for liver diseases characterized with hepatic steatosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsPolymorphism, Single NucleotideLipaseCarcinoma, HepatocellularLiver Neoplasms17-Hydroxysteroid DehydrogenasesGenetic Predisposition to DiseaseHepatitis B, ChronicHumansFemaleMaleMiddle AgedCase-Control StudiesPrognosisAdultTurkeyRisk FactorsProspective StudiesPhenotypeGenetic Association StudiesAcyltransferasesPhospholipases A2, Calcium-Independent

Substanzen

PNPLA3 protein, humanMembrane ProteinsLipaseHSD17B13 protein, humanTM6SF2 protein, human17-Hydroxysteroid DehydrogenasesAcyltransferasesPhospholipases A2, Calcium-Independent

Autor:innen und Institutionen

  • Marmara University School of Medicine, Division of Gastroenterology and Hepatology, Istanbul; Marmara University, Institute of Gastroenterology, Istanbul; Department of Medical Biology, School of Medicine, Recep Tayyip…
  • Marmara University, Institute of Gastroenterology, Istanbul; Department of Medical Biology, School of Medicine, Recep Tayyip Erdogan University, Rize; Marmara University, School of Medicine, Department of Medical Biolog…
  • 2Marmara University School of Medicine, Institute of Gastroenterology, Istanbul, Turkey. yilmz.demet@gmail.com.
  • Marmara University School of Medicine, Division of Gastroenterology and Hepatology, Istanbul, Turkey. osmanozdogan@yahoo.com.
  • Marmara University School of Medicine, Division of Gastroenterology and Hepatology, Istanbul, Turkey. drfgunduz@yahoo.com.

Zitieren

APA

Demirtas, C. O., Eren, F., Yilmaz, D., Ozdogan, O. C., & Gunduz, F. (2024). Does Genetic Variation in PNPLA3, TM6SF2 and HSD17B13 have a Role in the Development or Prognosis of Hepatocellular Carcinoma in Turkish Patients with Hepatitis B?. Journal of Gastrointestinal and Liver Diseases. https://doi.org/10.15403/jgld-5474

Vancouver

Demirtas CO, Eren F, Yilmaz D, Ozdogan OC, Gunduz F. Does Genetic Variation in PNPLA3, TM6SF2 and HSD17B13 have a Role in the Development or Prognosis of Hepatocellular Carcinoma in Turkish Patients with Hepatitis B?. Journal of Gastrointestinal and Liver Diseases. 2024. doi:10.15403/jgld-5474

BibTeX
@article{Demirtas2024,
  author = {Demirtas, Coskun Ozer and Eren, Fatih and Yilmaz, Demet and Ozdogan, Osman Cavit and Gunduz, Feyza},
  title = {Does Genetic Variation in PNPLA3, TM6SF2 and HSD17B13 have a Role in the Development or Prognosis of Hepatocellular Carcinoma in Turkish Patients with Hepatitis B?},
  journal = {Journal of Gastrointestinal and Liver Diseases},
  year = {2024},
  doi = {10.15403/jgld-5474}
}
Kostenlos starten →